Annual Shareholders Equity
$757.50 M
+$469.11 M+162.66%
December 31, 2024
Summary
- As of March 12, 2025, NAMS annual stockholders equity is $757.50 million, with the most recent change of +$469.11 million (+162.66%) on December 31, 2024.
- During the last 3 years, NAMS annual shareholders equity has risen by +$701.13 million (+1243.70%).
- NAMS annual shareholders equity is now at all-time high.
Performance
NAMS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$757.50 M
+$378.64 M+99.94%
December 31, 2024
Summary
- As of March 12, 2025, NAMS quarterly stockholders equity is $757.50 million, with the most recent change of +$378.64 million (+99.94%) on December 31, 2024.
- Over the past year, NAMS quarterly shareholders equity has increased by +$378.64 million (+99.94%).
- NAMS quarterly shareholders equity is now at all-time high.
Performance
NAMS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NAMS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +162.7% | +99.9% |
| 3 y3 years | +1243.7% | +99.9% |
| 5 y5 years | +10000.0% | +99.9% |
NAMS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1243.7% | at high | +1243.7% |
| 5 y | 5-year | at high | >+9999.0% | at high | +1243.7% |
| alltime | all time | at high | >+9999.0% | at high | +1243.7% |
NewAmsterdam Pharma Company NV Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $757.50 M(+162.7%) | $757.50 M(+99.9%) |
| Sep 2024 | - | $378.86 M(-2.2%) |
| Jun 2024 | - | $387.44 M(-5.9%) |
| Mar 2024 | - | $411.80 M(+42.8%) |
| Dec 2023 | $288.39 M | $288.39 M(-37.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $458.89 M(+6.7%) |
| Dec 2022 | $430.07 M(+662.9%) | $430.07 M(+123.2%) |
| Jun 2022 | - | $192.65 M(+241.7%) |
| Dec 2021 | $56.37 M(-1381.4%) | $56.37 M |
| Dec 2020 | -$4.40 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual stockholders equity?
- What is the all time high annual shareholders equity for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual shareholders equity year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly shareholders equity year-on-year change?
What is NewAmsterdam Pharma Company NV annual stockholders equity?
The current annual shareholders equity of NAMS is $757.50 M
What is the all time high annual shareholders equity for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual stockholders equity is $757.50 M
What is NewAmsterdam Pharma Company NV annual shareholders equity year-on-year change?
Over the past year, NAMS annual stockholders equity has changed by +$469.11 M (+162.66%)
What is NewAmsterdam Pharma Company NV quarterly stockholders equity?
The current quarterly shareholders equity of NAMS is $757.50 M
What is the all time high quarterly shareholders equity for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly stockholders equity is $757.50 M
What is NewAmsterdam Pharma Company NV quarterly shareholders equity year-on-year change?
Over the past year, NAMS quarterly stockholders equity has changed by +$378.64 M (+99.94%)